|
SIN3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.78350000004757E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.89990000030316E-07 |
| Normal-vs-Stage2 |
1.199140E-04 |
| Normal-vs-Stage3 |
3.175500E-03 |
| Normal-vs-Stage4 |
2.604800E-03 |
| Stage1-vs-Stage2 |
9.256000E-01 |
| Stage1-vs-Stage3 |
5.233200E-01 |
| Stage1-vs-Stage4 |
8.805000E-01 |
| Stage2-vs-Stage3 |
5.275200E-01 |
| Stage2-vs-Stage4 |
9.086200E-01 |
| Stage3-vs-Stage4 |
5.738400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14449999996958E-06 |
| Normal-vs-AfricanAmerican |
1.799820E-04 |
| Normal-vs-Asian |
8.989500E-04 |
| Caucasian-vs-AfricanAmerican |
9.651200E-01 |
| Caucasian-vs-Asian |
4.546200E-01 |
| AfricanAmerican-vs-Asian |
3.636200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53490000043277E-07 |
| Normal-vs-Female |
5.324300E-02 |
| Male-vs-Female |
4.257500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.778800E-04 |
| Normal-vs-Extreme_Weight |
3.0162999997696E-07 |
| Normal-vs-Obese |
2.324900E-03 |
| Normal-vs-Extreme_Obese |
4.12149999999833E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.313600E-01 |
| Normal_Weight-vs-Obese |
3.890000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.954200E-01 |
| Extreme_Weight-vs-Obese |
3.554000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.199200E-01 |
| Obese-vs-Extreme_Obese |
8.899800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.483200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.323900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.52280000054184E-07 |
| Normal-vs-Age(81-100Yrs) |
8.16170000000893E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.756800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.230230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.601900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.655850E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.066100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.473800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52740000000096E-05 |
| Normal-VS-Type2 PRCC |
2.06449999984315E-07 |
| Normal-VS-KIRP CIMP |
5.092400E-02 |
| Normal-VS-Unclassified PRCC |
2.375500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.779600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.266600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.360000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.067980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.491700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.540200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.7347016024778E-11 |
| Normal-vs-N1 |
2.746600E-01 |
| Normal-vs-N2 |
1.972980E-01 |
| N0-vs-N1 |
8.562700E-03 |
| N0-vs-N2 |
7.942300E-02 |
| N1-vs-N2 |
7.835400E-01 |
|
|
